New Tyrosine kinase inhibitor for renal cell carcinoma

[Guest guest]

" Researchers from Europe have reported that pazopanib is an active new tyrosine

kinase inhibitor for treating renal cell carcinoma. The details of this study

were presented at the Joint ECCO 15 – 34th ESMO Multidisciplinary Congress in

Berlin, September 20-24, 2009.[1] Pazopanib is an oral multi-kinase inhibitor

that has shown significant activity for treating renal cell carcinoma. At ASCO

2007, researchers presented the results of a Phase II trial of pazopanib for the

treatment of advanced renal cell carcinoma.[2] One-third of the patients had

failed a prior therapy. "

http://www.caring4cancer.com/go/cancer/news?NewsItemId=44064

FYI,

Lottie Duthu